
    
      Subjects that underwent PV isolation for paroxysmal or non-longstanding persistent AF and are
      free of arrhythmia at the end of the 3-month blanking period while taking ADT. Eligible
      subjects who sign the study informed consent form will be randomized into one of two study
      arms:

      PVI+ADT Group: continue ADT through 9 months follow-up PVI-ADT Group: no ADT through 9 months
      follow up
    
  